Luteinizing Hormone Releasing Hormone (LH-RH), salmon

CAT:
804-HY-P0243-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Luteinizing Hormone Releasing Hormone (LH-RH), salmon - image 1

Luteinizing Hormone Releasing Hormone (LH-RH), salmon

  • UNSPSC Description:

    Luteinizing Hormone Releasing Hormone (LH-RH), salmon (Salmon GnRH) is the hypophysiotropic decapeptide synthesized in the hypothalamus that plays a crucial role in the control of reproductive functions.
  • Target Antigen:

    GnRH Receptor
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Luteinizing_Hormone_Releasing_Hormone__LH-RH_,_salmon.html
  • Purity:

    99.69
  • Solubility:

    H2O
  • Smiles:

    O=C([C@H]1NC(CC1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(NCC(N[C@H](C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(NCC(N)=O)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O)CC6=CC=C(C=C6)O)=O)=O)CC7=CNC8=CC=CC=C78)=O
  • Molecular Weight:

    1212.31
  • References & Citations:

    [1]Moretti RM, et al. Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression. Endocr Relat Cancer. 2003 Jun;10(2):161-7.|[2]Horvath JE, et al. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15048-53.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    86073-88-3